Skip to main content
SpringerLink
Log in

Treatment, Prevention and Control

  • Chapter
Herpes Simplex Virus

Part of the book series: The Bloomsbury Series in Clinical Science ((BLOOMSBURY))

  • 156 Accesses

Abstract

The recent development of specific safe and highly efficacious chemotherapy (in particular acyclovir) has revolutionised the treatment of HSV infections. Prior to the introduction of acyclovir, treatment was limited largely to the use of extremely toxic drugs for the management of severe infections and also symptomatic treatment for the milder manifestations of the various diseases (including labial and genital herpes). In this chapter I review the pharmacology, toxicity and clinical uses of antiviral drugs for the treatment of all aspects, of HSV infection, including labial, genital, ocular, disseminated, neonatal and cerebral infections. In addition to a consideration of antiviral chemotherapy, I also review the role of immune modulation, the potential production and efficacy of vaccines to prevent genital or oral herpes, the management of genital herpes in pregnancy, the importance of health education in the control of herpes, and the management of the psychological problems associated with genital herpes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adler MW, Mindel A (1983) Genital herpes — hype or hope. Br Med J 286: 1767–1768

    Google Scholar 

  • Adler MW, Mindel A (1985) Genital infection. Antiviral Chemotherapy and Interpheron. Br Med Bull 41: 361–366

    Google Scholar 

  • Anderson WA, Kilbourne ED (1961) Immunisation of mice with inactivated herpes simplex virus. Proc Soc Exp Biol Med 107: 518–520

    PubMed  CAS  Google Scholar 

  • Andrews EB, Tilson HH, Hum BAL, Cordero JF and the Acyclovir in Pregnancy Advisory Committee (1988) Acyclovir in Pregnancy Registry: an observational epidemiologic approach. Am J Med 85 [suppl 2A]: 123–128

    PubMed  CAS  Google Scholar 

  • Arita I, Fenner F (1985) Complicators of smallpox vaccination. In: Quinnan GU Jr (ed). Vaccinia viruses as vectors for vaccine antigens. Elsevier, New York pp 48–60

    Google Scholar 

  • Ashley RL, Corey L (1983) Development of antibodies to a herpes simplex virus type 2 (HSV 2) subunit vaccine in seropositive and seronegative volunteers. In: Abstracts of papers presented at an international herpes virus workshop, p 262

    Google Scholar 

  • Bauer DJ (1977) The specific treatment of virus disease. University Park Press, Baltimore, OH. Belsey EM, Adler MW (1978) Current approaches to the diagnosis of herpes genitalis. Br J Vener Dis 54: 115–117

    Google Scholar 

  • Binkin NJ, Koplan JP, Cates W (1984) Preventing neonatal herpes. The value of weekly viral cultures in pregnant women with recurrent genital herpes. JAMA 251: 2816–2821

    Google Scholar 

  • Blank H, Haines HG (1973) Experimental human reinfection with herpes simplex virus. J Invest Dermatol 61: 223–225

    PubMed  CAS  Google Scholar 

  • Bodey GP, Gottlieb J, McCredie KB, Freireich EJ (1975) Adenine arabinoside in cancer chemotherapy. In: Pavan-Langston D, Buchanan RA, Alford CA, Jr (eds) Adenine arabinoside: an antiviral agent. Raven Press, New York pp 281–285

    Google Scholar 

  • Bouffat P, Saurat JH (1980) Isoprinosine as a therapeutic agent in recurrent mucocutaneous infections due to herpes virus. Int J Immunopharmacol 2: Abstract.

    Google Scholar 

  • Brigden D (1985) Skin infections. Antiviral chemotherapy and interferon. Br Med Bull 41: 357–360

    PubMed  CAS  Google Scholar 

  • Brown ZA, Vontver LA, Benedetti J et al (1987) Effects on Infants of a first episode of genital herpes during pregnancy. N Engl J Med 317: 1246–1251

    PubMed  CAS  Google Scholar 

  • Bryson YJ, Dillon M, Lovett M et al. (1983) Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. N Engl J Med 308: 916–921

    PubMed  CAS  Google Scholar 

  • Buchanan RA, Hess F (1980) Vidarabine ( ViraA) pharmacology and clinical experience. Pharmacol Ther 8: 143–171

    Google Scholar 

  • Burns WH, Saral R, Santos GW, et al. (1982) Isolation and characterisation of resistant herpes simplex virus after acyclovir therapy. Lancet i: 421–423

    Google Scholar 

  • Cappel R, De Cuyper F, De Braekeeler J (1979) Antibody and cell mediated immunity to a DNA free herpes simplex subunit vaccine. Dev Biol Stand 43: 381–385

    PubMed  CAS  Google Scholar 

  • Cappel R, Sprecher S, De Cuyper F, De Braekeleer J (1985) Clinical efficacy of a herpes simplex subunit vaccine. J Med Virol 16: 137–145

    PubMed  CAS  Google Scholar 

  • Carter CA, Hartley CE, Skinner GRB, Turner SP, Easty DL (1981) Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine. Br J Ophthalmol 65: 679–682

    Google Scholar 

  • Chan WL (1983) Protective immunisation of mice with specific HSV 1 glycoproteins. Immunology 49: 343–352

    PubMed  CAS  Google Scholar 

  • Cheng YC, Dutschman G, Fox JJ, Watanabe KA, Machida H (1981) Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob Agents Chemother 20: 420–423

    PubMed  CAS  Google Scholar 

  • Chou S, Gallagher JG, Merigan TC (1981) Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infections. Lancet i: 1392–1394

    Google Scholar 

  • Coen CM, Schaffer PA (1981) Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc Natl Acad Sci USA 77: 2265–2269

    Google Scholar 

  • Colin J, Tournoux A, Chastel C, Reynard G (1981) Superficial herpes simplex keratitis. Double blind comparative trial of acyclovir and idoxuridine. Nouv Press Med 10: 2969–2975

    Google Scholar 

  • Collum LMT, Benedict-Smith A, Hilary IB (1980) Randomised double blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol 64: 766–769

    PubMed  CAS  Google Scholar 

  • Collum LMT, Logan P, Ravenscroft T (1983) Acyclovir ( Zovirax) in herpetic disciform keratitis. Br J Ophthalmol 67: 115–118

    Google Scholar 

  • Committee on Fetus and Newborn (1980) Perinatal herpes simplex virus infections. Pediatrics 66: 147–148

    Google Scholar 

  • Corey L (1985) Genital Herpes. In: Holmes KK, Mardh P-A, Sparling PF, Wiesner PJ (eds) Sexually transmitted diseases. McGraw-Hill Book Company, New York pp 449–474

    Google Scholar 

  • Corey L (1986) Genital herpes simplex virus infections: natural history and therapy. In: Oriel J D, Harris JRW (eds) Recent advances in sexually transmitted diseases, vol 3, Churchill Livingstone, Edinburgh, pp 71–108

    Google Scholar 

  • Corey L, Holmes KK (1983) Genital herpes simplex virus infections: current concepts in diagnosis, therapy and prevention. Ann Intern Med 98: 973–983

    PubMed  CAS  Google Scholar 

  • Corey L, Spear PG (1986) Infections with herpes simplex viruses. (Second of two parts.) N Engl J Med 314: 749–757

    CAS  Google Scholar 

  • Corey L, Reeves WC, Chiang WT et al. (1978) Ineffectiveness of topical ether for the treatment of herpes simplex virus infection. N Engl J Med 299: 237–239

    PubMed  CAS  Google Scholar 

  • Corey L, Chiang WT, Reeves WC, Stamm WE, Brewar L, Holmes KK (1979) Effect of Isoprinosine on the cellular immune response in initial genital herpes virus infection. Clin Res 27: 41A

    Google Scholar 

  • Corey L, Nahmias AJ, Guinan ME, Benedetti JK, Critchlow CW, Holmes KK (1982) A trial of topical acyclovir in genital herpes virus infections. N Engl J Med 306: 1313–1319

    PubMed  CAS  Google Scholar 

  • Corey L, Fife KH, Benedetti JK et al (1983) Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med 98: 914–921

    PubMed  CAS  Google Scholar 

  • Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J, Adler MW (1985) Risk of recurrence after treatment of first episode genital herpes with intravenous acyclovir. Sex Transm Dis 12: 215–218

    PubMed  CAS  Google Scholar 

  • Coster DJ, Jones BR, McGill J (1979) Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine. Br J Ophthalmol 63: 418–421

    PubMed  CAS  Google Scholar 

  • Coster DJ, Jones BR, McGill J (1979) Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine. Br J Ophthalmol 63: 418–421

    PubMed  CAS  Google Scholar 

  • Coster DJ, Wilhelmus KR, Michaud R, Jones BR (1983) A comparison of acyclovir and idoxuridine in treatment for ulcerative herpetic keratitis. Br J Ophthalmol 95: 175–181

    Google Scholar 

  • Cremer KJ, Mackett M, Wohlenberg C, Notkins AL, Moss B (1985) Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228: 737–740

    PubMed  CAS  Google Scholar 

  • Crumpacker CS, Schnipper LE, Marlow SI, Kowalsky PN, Hershey BJ, Levin MJ (1982) Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med 306: 343–346

    PubMed  CAS  Google Scholar 

  • Csonka GW, Tyrrell DAJ (1984) Treatment of herpes genitalis with carbenoxolone and cicloxolone cream: a double blind placebo controlled clinical trial. Br J Vener Dis 60: 178–181

    PubMed  CAS  Google Scholar 

  • Dargan DJ, Subak-Sharpe JH (1986) The antiviral activity against herpes simplex virus of the triterpenoid compounds carbenoxolone sodium and cicloxolone sodium. J Antimicrob Chemother 18 [suppl B]: 185–200.

    PubMed  CAS  Google Scholar 

  • Dawson CR (1984) Ocular herpes simplex virus infections. Clin Dermatol 2: 56–66

    PubMed  CAS  Google Scholar 

  • De Clercq E (1985) Recent trends and development in antiviral chemotherapy. In Proceedings of the First International TNO Conference on Antiviral Research; Rotterdam. Antiviral Res [Suppl 1 ): 11–19

    Google Scholar 

  • De Clercq E, Descamps J, De Somer P, Barr PJ, Jones AS, Walker RT (1979) (E)-5-(2-bromovinyl)-2’-deoxyuridine: a potent and selective anti-herpes agent. Proc Natl Acad Sci USA 76: 2947–2951

    PubMed  Google Scholar 

  • Derman RJ (1986) Counselling the herpes genitalis patient. J Reprod Med 31 [suppl]: 439–444

    PubMed  CAS  Google Scholar 

  • Douglas JM, Critchlow C, Benedetti J et al. (1984) A double blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 310: 1551–1556

    PubMed  CAS  Google Scholar 

  • Eisenberg JR, Cerini PC, Heilman CJ, et al (1985) Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J Virol 56: 1014–1017

    PubMed  CAS  Google Scholar 

  • Elion GB (1982) Mechanism of action and selectivity of acyclovir. Am J Med 73 [suppl 1A]: 7–13

    PubMed  CAS  Google Scholar 

  • Ertl HCJ, Finberg RW (1984) Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotype antibody directed against a helper T-cell clone. Proc Natl Acad Sci USA 81: 2850–2854

    PubMed  CAS  Google Scholar 

  • Farrell RG, Nesland RS (1977) Topical ethyl ether therapy of herpes simplex infections. J Am Coll Emerg Physic 6: 372–373

    CAS  Google Scholar 

  • Fawcett HA, Wansbrough-Jones MH, Clark AE, Leigh IM (1983) Prophylactic topical acyclovir for frequent recurrent herpes simplex infection with and without erythema multiforme. Br Med J 287: 98–99

    Google Scholar 

  • Field HJ, Darby G, Wildy P (1980) Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol 49: 115–124

    PubMed  CAS  Google Scholar 

  • Fiddian AP, Ivanyi L (1983) Topical acyclovir in the management of recurrent herpes labialis. Br J Dermatol 109: 321–326

    PubMed  CAS  Google Scholar 

  • Fiddian AP, Yeo JM, Stubbings R, Dean D (1983a) Successful treatment of herpes labialis with topical acyclovir. Br J Med 286: 1699–1700

    CAS  Google Scholar 

  • Fiddian AP, Kinghorn GR, Golmeier D et al. (1983b) Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy. J Antimicrob Chemother. 12 [suppl B]: 67–77

    PubMed  Google Scholar 

  • Furman PA, St Clair MH, Fyfe JA, Rideout JL, Keller PM, Elion GB (1979) Inhibition of herpes simplex virus induced DNA polymerase activity and viral DNA replication by 9-(2- hydroxyethoxymethyl)guanine and its triphosphate. J Med Virol 32: 72–77

    CAS  Google Scholar 

  • Fyfe JA (1982) Differential phosphorylation of (E)-5-(2-bromovinyl-2’-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus. Mol Pharmacol 21: 432–437

    PubMed  CAS  Google Scholar 

  • Galli M, Lazzarin A, Moroni M, Zanussi C (1982) Inosiplex in recurrent herpes simplex infections. Lancet ii: 331–332

    Google Scholar 

  • Gaub J, Pedersen C, Poulson A-G, et al (1987) The effect of Foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients. AIDS 1: 27–33

    Google Scholar 

  • Glezerman M, Lunenfeld E, Cohen V, et al. (1988) Placebo-controlled trial of topical interferon in labial and genital herpes. Lancet i: 150–152

    Google Scholar 

  • Gold D, Benedetti J, Corey L (1986) Topical surfactant therapy for recurrent herpes simplex infection. Lancet ii: 283

    Google Scholar 

  • Goldberg CB (1986) Controlled trial of “Intervir-A” in herpes simplex virus infection. Lancet i: 703–706

    Google Scholar 

  • Goldman L (1961) Reactions of an auto inoculation for recurrent herpes simplex. Arch Dermatol 84: 1025–1026

    PubMed  CAS  Google Scholar 

  • Halsos AM, Salo OP, Lassus A, et al. (1985) Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo controlled cross-over study. Acta Derm Venereol (Stockh) 65: 59–63

    CAS  Google Scholar 

  • Hann IM, Prentice HG, Blacklock HA, et al (1983) Acyclovir prophylaxis against herpes virus infection in severely immunocompromised patients: randomised double blind trial. Br Med J 287: 384–388

    CAS  Google Scholar 

  • Heidelberger C, King D (1979) Trifluorothymidine. Pharmacol Ther 6: 427–442

    CAS  Google Scholar 

  • Herrman EC Jr (1961) Plaque inhibition test for detection of specific inhibitors of DNA containing viruses. Proc Soc Exp Biol Med 107: 142–145

    PubMed  Google Scholar 

  • Hilleman MR, Larson VH, Lehman ED, et al (1981) Sub-unit herpes simplex virus-2 vaccines In: Nahmias AJ, Dowdle WR, Schinazi RF (eds) The human herpesviruses. Elsevier, New York, pp 503–506

    Google Scholar 

  • Huang ES, Huang CH, Huong SM, Selgrade M (1976) Preferential inhibition of herpes group viruses by phosphonoacetic acid: effect on virus DNA synthesis and virus-induced DNA polymerase activity. Yale J Biol Med 49: 93–98

    PubMed  CAS  Google Scholar 

  • Jones BR, Coster DJ, Falcon MG, Cantell K (1976) Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet ii: 128

    Google Scholar 

  • Kaerner HC, Schroder CH, Ott-Hartmann A, Kummel G, Kircher H (1983) Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a non-pathogenic herpes simplex virus type 1 virus strain in mouse brain. J Virol 46: 83–93

    PubMed  CAS  Google Scholar 

  • Kennedy RC, Dreesman GR (1984) Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of anti-idiotype induces anti-HBs that express a similar idiotype. J Exp Med 159: 655–665

    Google Scholar 

  • Kinghorn GR, Turner EB, Barton IG, Potter CW, Burke CA, Fiddian AP (1983) Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes. Antiviral Res 3: 291–301

    PubMed  CAS  Google Scholar 

  • Kinghorn GR, Jeavons M, Rowland M et al. (1985) Acyclovir prophylaxis of recurrent genital herpes: a randomised placebo controlled crossover study. Genitourin Med 61: 387–390

    PubMed  CAS  Google Scholar 

  • Kit S, Quavi H, Dubbs DR, Otsuka H (1983) Attenuated marmoset herpes virus isolated from recombinants of virulent marmoset herpes virus and hybrid plasmids. J Med Virol 12: 25–36

    PubMed  CAS  Google Scholar 

  • Kitces EN, Morahan PS, Tew JG, Murray BK (1977) Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine. Infect Immun 16: 955–960

    PubMed  CAS  Google Scholar 

  • Klein RJ, Buimovici-Klein E, Mosur H, Moucha R, Hilfenhaus J (1981) Efficacy of a virion envelope herpes simplex virus against experimental skin infections in hairless mice. Arch Virol 68: 73–80

    PubMed  CAS  Google Scholar 

  • Kutinova L, Vonka V, Stichtova V (1980) Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus. Acta Virol (English Edition) 24: 391–398

    CAS  Google Scholar 

  • La Lau C, Oosterhuis JA, Versteeg J, et al. (1982) Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial. Br J Opthalmol 66: 506–508

    Google Scholar 

  • Lasky LA, Dowbenko D, Simonson C, Berman PW (1984) Production of an HSV subunit vaccine by genetically engineered mammalian cell lines. In: Chanock RM, Lerner RA (eds) Modern approaches to vaccines: molecular and chemical basis of virus virulence and immunogenicity. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY pp 189–194

    Google Scholar 

  • Lazar MP (1956) Vaccination for recurrent herpes simplex infection: initiation of a new disease site following the use of unmodified material containing the live virus. Arch Dermatol 73: 70–71

    CAS  Google Scholar 

  • Lee FK, Coleman RM, Pereira L, Bailey PD, Tatsuno M, Nahmias AJ (1985) Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 22: 641–644

    PubMed  CAS  Google Scholar 

  • Lee FK, Pereira L, Griffin C, Reid E, Nahmias A (1986) A novel glycoprotein for detection of herpes simplex virus type 1 specific antibodies. J Virol Methods 14: 111–118

    PubMed  CAS  Google Scholar 

  • Leigh IM (1988) The management of nongenital herpes simplex virus infection in immunocompetent patients. Am J Med 85 [suppl 2A]: 34–38

    PubMed  CAS  Google Scholar 

  • Levaditi C (1926) L’herpes et le zona. Masson, Paris.

    Google Scholar 

  • Long D, Madara TJ, Ponce de Leon M, Cohen GH, Montgomery PC, Eisenberg RJ (1985) Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infect Immun 43: 761–764

    Google Scholar 

  • Macher E (1957) Zur Behandlung des chronisch-rezivienrenden herpes simplex. Z Hautkr 23: 18–22

    CAS  Google Scholar 

  • Mao JCH, Robishaw EE (1975) Mode of inhibition of herpes simplex virus DNA polymerase by phosphonoacetate. Biochemistry 14: 5475–5479

    PubMed  CAS  Google Scholar 

  • McCulley JP, Binder PS, Kaufman HE, O’Day DM, Poirier RH (1982) A double blind multicenter clinical trial of acyclovir vs idoxuridine for treatment of epithelial herpes simplex keratitis. Opthalmology 89: 1195–1200

    CAS  Google Scholar 

  • McGill JI (1984) Antiviral treatment of herpes simplex stroma disease. In: Maudgal P (ed) Herpetic eye disease. Junk, Berlin pp 217–221

    Google Scholar 

  • McGill J, Scott GM (1985) Viral keratitis. Br Med Bull 41: 351–356

    PubMed  CAS  Google Scholar 

  • McGill J, Tormey P, Walker CD (1981) Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Opthalmol 65: 610–613

    CAS  Google Scholar 

  • McClaren C, Corey L, Dekker C, Barry DW (1983) In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir treated patients. J Infect Dis 148: 868–875

    Google Scholar 

  • Meignier B (1985) Vaccination against herpes simplex virus infections. In: Roizman B, Lopez C (eds) The herpes viruses, vol 4, Plenum Press, New York pp 265–296

    Google Scholar 

  • Mertz GJ, Critchlow CW, Benedetti J, et al (1984) Double blind placebo controlled trial of oral acyclovir in first episode genital herpes simplex virus infection. JAMA 252: 1147–1151

    Google Scholar 

  • Mertz GJ, Jones CC, Mills J et al (1988) Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 260: 201–266

    Google Scholar 

  • Meyers JD, Wade JC, Mitchell CD, et al. (1982) Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 73: 229–235

    PubMed  CAS  Google Scholar 

  • Meyrick Thomas RH, Dodd HJ, Yeo JM, Kirby JP (1985) Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection. Br J Dermatol 113: 731–735

    Google Scholar 

  • Miller WH, Miller RL (1980) Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. J Bio Chem 255: 7204–7207

    CAS  Google Scholar 

  • Mindel A (1984) Treatment and prevention of herpes genital infection. J Antimicrob Chemother 14 [suppl A]: 75–83

    PubMed  Google Scholar 

  • Mindel A, Carney O (1988) Acyclovir malabsorption. Br Med J 296: 1605

    CAS  Google Scholar 

  • Mindel A, Sutherland S (1983) Genital herpes - the disease and its treatment including intravenous acyclovir. J Antimicrob Chemother 12 [suppl B]: 51–59

    PubMed  Google Scholar 

  • Mindel A, Adler MW, Sutherland S, Fiddian AP (1982) Intravenous acyclovir treatment for primary genital herpes. Lancet i: 697–700

    PubMed  CAS  Google Scholar 

  • Mindel A, Weller IVD, Faherty A, et al. (1984) Prophylactic oral acyclovir in recurrent genital herpes. Lancet ii: 57–59

    PubMed  CAS  Google Scholar 

  • Mindel A, Weller IVD, Faherty A, Sutherland S, Fiddian AP, Adler MW (1986) Acyclovir in first attacks of genital herpes and prevention of recurrences. Genitourin Med 62: 28–32

    PubMed  CAS  Google Scholar 

  • Mindel A, Kinghorn G, Allason-Jones E, et al. (1987) Treatment of first-attack genital herpes acyclovir versus inosine pranobex. Lancet i: 1171–1173

    PubMed  CAS  Google Scholar 

  • Mindel A, Faherty A, Carney O, Patou G, Williams P (1988) The efficacy, dosage and safety of longterm suppressive acyclovir for the treatment of recurrent genital herpes. Lancet i: 926–928

    PubMed  CAS  Google Scholar 

  • Mindel A, Carney O, Sonnex C, Freris M, Patou G, William P (1989) Suppression of frequently recurring genital herpes. Acyclovir versus inosine pranobex. Genitourin Med 65: 103–105

    Google Scholar 

  • Mitchell CD, Bean B, Gentry SR, Groth KE, Boen JR, Balfour HH (1981) Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet i: 1389–1392

    PubMed  CAS  Google Scholar 

  • Mocarski ES, Post LE, Roizman B (1980) Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversion. Cell 22: 243–255

    PubMed  CAS  Google Scholar 

  • Muller WEG (1977) Rational design of arabinosyl nucleosides as antitumor and antiviral agents. Jpn J Antibiot 30 [suppl]: S104–S120

    Google Scholar 

  • Muller WEG (1979) Mechanism of action and pharmacology: chemical agents. In: Galasso G J, Merigan TC, Buchanan RA (eds) Antiviral agents and viral diseases of man. 1st edn, Raven Press, New York, pp 77–149

    Google Scholar 

  • Nahmias AJ, Keyserling HL (1984) Neonatal herpes simplex in context of the Torch complex. In: Holmes KK, Mardh P, Sparling PF, Wiesner PJ (eds) Sexually transmitted diseases. McGraw- Hill Book Company, New York, pp 816–826

    Google Scholar 

  • Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH (1971) Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 110: 825–837

    PubMed  CAS  Google Scholar 

  • Nasemann TH, Wassilew SW (1979) Vaccination for herpes simplex genitalis. Br J Vener Dis 55: 121–122

    PubMed  CAS  Google Scholar 

  • Nilsen AE, Aasen T, Halsos AM et al. (1982) Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet ii: 571–573

    PubMed  CAS  Google Scholar 

  • Oberg B (1983) Antiviral effects of phosphonoformate (PFA, Foscarnet sodium). Pharmacol Ther 19: 387–415

    Google Scholar 

  • Overall JC Jr (1984) Dermatologic viral diseases. In: Galasso GJ, Merigan TC, Buchanan RA (eds) Antiviral agents and viral diseases of man, 2nd edn, Raven Press, New York, pp 247–312

    Google Scholar 

  • Panscherewski D, Rhode B (1957) Zur Serologic und Therapie des Herpes Simplex recidivans. Hautarzt 13: 275–278

    Google Scholar 

  • Paoletti E, Panicali D (1984) Genetically engineered pox viruses as live recombinant vaccines. In: Chanock RM and Lerner RA (eds) Modern approaches to vaccines — molecular and chemical basis of virus virulence and immunospecificity. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 295–299

    Google Scholar 

  • Partridge M, Poswillo DE (1984) Topical carbonoxolone sodium in the management of herpes simplex infections. Br J Oral Maxillofac Surg 22: 138–145

    PubMed  CAS  Google Scholar 

  • Patterson A, Jones BR (1967) The management of ocular herpes. Trans Opthalmol Soc UK 87: 59–84

    CAS  Google Scholar 

  • Pavan-Langston D (1984) Ocular viral diseases. In: Galasso GJ, Merigan TC, Buchanan RA (eds) Antiviral agents and viral diseases of man, 2nd edn. Raven Press, New York, pp 207–245

    Google Scholar 

  • Pazin GJ, Harger JH (1986) Management of oral and genital herpes simplex virus infection: diagnosis and treatment. DM 32: 725–824

    PubMed  CAS  Google Scholar 

  • Post LE, Roizman B (1981) A generalised technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth in cell culture. Cell 25: 227–232

    PubMed  CAS  Google Scholar 

  • Post LE, Mackem S, Roizman B (1981) The regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with a gene promoters. Cell 34: 555–556

    Google Scholar 

  • Poswillo DE, Roberts GJ (1981) Topical carbonoxolone for orofacial herpes simplex infection. Lancet ii: 143–144

    PubMed  CAS  Google Scholar 

  • Price RW, Walz MA, Wohlenberg C, Notkins AL (1975) Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunisation. Science 188: 938–940

    PubMed  CAS  Google Scholar 

  • Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AA, Arvin AM (1987) Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infection. N Engl J Med 316: 240–244

    PubMed  CAS  Google Scholar 

  • Prusoff WH (1959) Synthesis and biological activities of iododeoxyuridine, an analog of thymidine. Biochem Biophys Acta 132: 295–296

    Google Scholar 

  • Prusoff WH, Goz B (1975) Halogenated pyrimidine deoxyribonucleosides. In: Eichler O, Herken F H, Welch AD (eds) Handbook of experimental pharmacology, vol 38, part 2. Springer, Berlin, Heidelberg, New York, pp 272–347

    Google Scholar 

  • Prusoff WH, Ward DC (1976) Commentary: nucleosides analogs with antiviral activity. Biochem Pharmacol 25: 1233–1239

    PubMed  CAS  Google Scholar 

  • Prusoff WH, Chen MS, Fischer PH, et al. (1979) Antiviral iodinated pyrimidine deoxyribonucleosides: 5-iodo-2’-deoxyuridine; 5-iodo-2’-deoxycytidine; 5-iodo-5’-amino-2’,5’-dideoxyuridine. Pharmacol Ther 7: 1–34

    PubMed  CAS  Google Scholar 

  • Raborn GW, McGaw WT, Grace M, Percy J (1988) Treatment of herpes labialis with acyclovir: review of three clinical trials. Am J Med 85 [suppl 2A]: 39–42

    PubMed  CAS  Google Scholar 

  • Reagan KJ, Wunner WH, Koprowski H (1985) Viral antigen-independent immunization: induction by anti-idiotypic antibodies of neutralizing antibodies to defined epitopes on rabies virus glycoprotein,. In: Dreesman GR, Bronson JG, Kennedy RC (eds) High technology route to virus vaccines. Am Soc Microbiol, Washington DC, pp 117–124

    Google Scholar 

  • Reichman RC, Badger GJ, Mertz GJ, et al. (1984) Treatment of recurrent genital herpes simplex infection with oral acyclovir: a controlled trial. JAMA 251: 2103–2107

    PubMed  CAS  Google Scholar 

  • Roizman B, Arsenakis M (1985) Genetic engineering of herpes simplex virus genomes for attentuation and expression of foreign genes. In: Quinnan G U Jr (ed). Vaccinia viruses as vectors for vaccine antigens. Elsevier, New York, pp 211–223

    Google Scholar 

  • Sacks SL, Portnoy J, Lawee D et al. (1987) Clinical course of recurrent genital herpes and treatment with Foscarnet cream: results of a Canadian multicenter trial. J Infect Dis 155: 178–186

    PubMed  CAS  Google Scholar 

  • Salo O, Lassus A (1983) Treatment of recurrent genital herpes with isoprinosine. Eur J Sex Trans Dis 1: 101–105

    Google Scholar 

  • Salo OP, Lassus A, Hovi R, Fiddian AP (1983) Double blind placebo controlled trial of oral acyclovir in recurrent genital herpes. Eur J Sex Trans Dis 1: 95–98

    Google Scholar 

  • Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS (1981) Acyclovir prophylaxis of herpes simplex virus infections. A randomised, double-blind, controlled trial in bone-marrow transplant recipients. N Engl J Med 305: 63–67

    Google Scholar 

  • Saral R, Ambinder RF, Burns WH et al. (1983) Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. Ann Intern Med 99: 773–776

    PubMed  CAS  Google Scholar 

  • Schadelin J, Schilt U, Rohner M (1988) Prevention of labialis following trigeminal surgery. Am J Med 85 [suppl 2A]: 46–48

    PubMed  CAS  Google Scholar 

  • Schinazi RF, Del Bene V, Taylor Scott R, Dudley-Thorpe J (1986) Characterisation of acyclovir resistant and sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency. J Antimicrob Chemother 18 [suppl B]: 127–134

    PubMed  Google Scholar 

  • Schnipper LE, Crumpacker CS (1980) Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci. Proc Natl Acad Sci USA 77: 2270–2273

    PubMed  CAS  Google Scholar 

  • Scriba M (1978) Protection of guinea pigs against primary and recurrent genital herpes infection by immunization with live heterologous or homologous herpes simplex virus: implication for a herpes virus vaccine. Med Microbiol Immunol 166: 63–69

    PubMed  CAS  Google Scholar 

  • Sege K, Peterson PA (1978) Use of anti-idiotypic antibodies as cell surface receptor probes. Proc Natl Acad Sci USA 75: 2443–2447

    PubMed  CAS  Google Scholar 

  • Sharpe AH, Gaulton GN, McDade KK, Fields BN, Greene MI (1984) Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med 160: 1195–1205

    PubMed  CAS  Google Scholar 

  • Shaw M, King M, Best JM, Banatvala JE, Gibson JR, Klaber MR (1985) Failure of acyclovir cream in treatment of recurrent herpes labialis. Br Med J 291: 7–9

    CAS  Google Scholar 

  • Sibrack CD, Gutman LT, Wilfert CM, et al. (1982) Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis 146: 673–682

    PubMed  CAS  Google Scholar 

  • Skinner G, Buchan A, Hartley CE, Turner SP, William DR (1980) The preparation, efficacy and safety of “antigenoid” vaccine NFU(S-L+) MRC towards prevention of herpes simplex virus infections in human subjects. Med Microbiol Immunol 169: 39–51

    PubMed  CAS  Google Scholar 

  • Skinner GRB, Woodman G, Hartley CE, et al. (1982a) Early experience with “antigenoid” vaccine Ac NFU (S-) MRC towards prevention and modification of herpes genitalis. Dev Biol Stand 52: 333–344

    PubMed  CAS  Google Scholar 

  • Skinner GRB, Woodman GB, Hartley CE, et al. (1982b) Preparation and immunogenicity of vaccine Ac NFU (S-) MRC towards the prevention of herpes genitalis. Br J Vener Dis 58: 381–386

    PubMed  CAS  Google Scholar 

  • Skinner GRB, Buchan A, Durham J et al. (1987) Role of bovine mammillitis virus towards preparation of an alternative vaccine against herpes simplex virus infections of human subjects. Vaccine 5: 55–59

    PubMed  CAS  Google Scholar 

  • Skoldenberg B, Forsgren M, Alestig K, et al. (1984) Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet ii: 707–711

    Google Scholar 

  • Slichtova V, Kutinova L, Vonka V (1980) Immunogenicity of subviral herpes virus type 1 preparation: protection of mice against intradermal challenge with type 1 and type 2 viruses. Arch Virol 66: 207–214

    PubMed  CAS  Google Scholar 

  • Spruance SL (1988) Cutaneous herpes simplex virus lesions induced by ultraviolet radiation: a review of model systems and prophylactic therapy with oral acyclovir. Am J Med 85 [suppl 2A]: 43–45

    PubMed  CAS  Google Scholar 

  • Spruance SL, Schnipper LE, Overall JC Jr., et al. (1982) Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis 146: 85–90

    PubMed  CAS  Google Scholar 

  • Straus SE, Takiff HE, Seidlin M, et al. (1984) Suppression of frequently recurring genital herpes. A placebo controlled double blind trail of oral acyclovir. N Engl J Med 316: 1545–1550

    Google Scholar 

  • Sugar J, Kaufman HE (1973) Halogenated pyrimidines in antiviral therapy. In: Carter W A (ed) Selective inhibition of viral functions. CRC Press, Cleveland, OH, pp 295–311

    Google Scholar 

  • Sullivan-Bolyai J, Hill HF, Wilson C, Corey L (1983) Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlates. JAMA 250: 3059–3062

    Google Scholar 

  • Taylor CA, Hendley SO, Greer KE, Gwaltney JM (1977) Topical treatment of herpes labialis with chloroform. Arch Dermatol 113: 1550–1552

    PubMed  CAS  Google Scholar 

  • Thin RN, Nabarro JM, Davidson Parker J, Fiddian AP (1983) Topical acyclovir in the treatment of initial genital herpes. Br J Vener Dis 59: 116–119

    PubMed  CAS  Google Scholar 

  • Thin RN, Jeffries, DJ, Taylor PK, et al. (1985) Recurrent genital herpes suppressed by oral acyclovir: a multicentre double-blind trial. J Antimicrob Chemother 16: 219–226

    PubMed  CAS  Google Scholar 

  • Thompson RL, Stevens J (1983) Replication of body temperature selects a neurovirulent herpes simplex virus type 2. Infect Immun 41: 855–857

    PubMed  CAS  Google Scholar 

  • Thompson TA, Murray BK, Morahan PS, Cline P (1981) Protective studies on several herpes simplex type 1 vaccine preparations in a mouse labial infection model. In: Nahmias AJ, Dowdle WR, Schinazi RF (eds) The human herpesviruses. New York, Elsevier, pp 649–650

    Google Scholar 

  • Thompson TA, Hilfenhaus J, Mosar H, Morahan PS (1983) Comparison of effects of adjuvants in efficacy of virion envelope herpes simplex virus vaccine against labial infection of Balb/c mice. Infect Immun 41: 556–562

    Google Scholar 

  • Thornton B, Griffiths JB, Walkland A (1982) Herpes simplex vaccine using cell membrane associated antigen in animal models. Dev Biol Stand 50: 201–206

    Google Scholar 

  • Uytdehaag IGCM, Osterhaus ADME (1985) Induction of neutralising antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody. J Immunol 134: 1225–1229

    PubMed  CAS  Google Scholar 

  • Van Etta L, Brown J, Mastri A, Wilson T (1981) Fatal vidarabine toxicity in a patient with normal renal function. JAMA 246: 1703–1705

    PubMed  Google Scholar 

  • Vontver LA, Reeves WC, Rattray M et al (1979) Clinical course and diagnosis of genital herpes simplex virus infection and evaluation of topical surfactant therapy. Am J Obstet Gynecol 133: 548–554

    PubMed  CAS  Google Scholar 

  • Wade C, Newton B, McLaren C, Flournoy N, Keeney RE (1982) Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation. Ann Intern Med 96: 265–269

    PubMed  CAS  Google Scholar 

  • Wade JC, McLaren C, Meyers JD (1983) Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses treatment with acyclovir. J Infect Dis 148: 1077–1082

    PubMed  CAS  Google Scholar 

  • Wade JC, Newton B, Flournoy N, Meyers JD (1984) Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 100: 823–828

    PubMed  CAS  Google Scholar 

  • Wallin J, Lernestedt JO, Ogenstad S, Lycke E (1985) Topical treatment of recurrent genital herpes infection with Forscarnet. Scand J Infect Dis 17: 165–172

    PubMed  CAS  Google Scholar 

  • Watson RJ, Enquist L (1985) Genetically engineered herpes simplex virus vaccines. In: Melnick J L (ed) Progress in medical virology, vol 31. Karger, Basel pp. 84–108

    Google Scholar 

  • Weller IVD, Carreno V, Fowler MJF, et al (1983) Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with IV bolus administration. J Antimicrob Chemother 11: 223–231

    PubMed  CAS  Google Scholar 

  • Whitley RJ (1988) Herpes simplex infection of the central nervous system. Am J Med 85 [suppl 2A]: 61–67

    PubMed  CAS  Google Scholar 

  • Whitley RJ, Ch’ien LT, Dolin R, Galasso GJ, Alford CA Editors and the collaborative study group (1976). Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med 294: 1193–1199

    Google Scholar 

  • Whitley RJ, Soong SJ, Dolin R, et al. (1977) Adenine arabinoside therapy of biopsy-proved herpes simplex virus encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med 297: 289–294

    Google Scholar 

  • Whitley RJ, Tucker BC, Kinkel AW, et al. (1980a) Pharmacology, tolerance and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother 18: 709–715

    PubMed  CAS  Google Scholar 

  • Whitley RJ, Nahmias AJ, Soong SJ, Galasso GJ, Fleming CL, Alford CA (1980b) Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 66: 495–501

    PubMed  CAS  Google Scholar 

  • Whitley RJ, Soon SJ, Linneman C, Liu C, Pazin G, Alford CA (1982) Herpes simplex encephalitis. JAMA 247: 317–320

    PubMed  CAS  Google Scholar 

  • Whitley RJ, Alford CA, Hirsch MS, et al (1986) Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 314: 144–149

    PubMed  CAS  Google Scholar 

  • Woodman CBJ, Buchan A, Fuller A, et al. (1983) Efficacy of a vaccine Ac NFU, (S-) MRC5 given after an initial clinical episode in the prevention of herpes genitalis. Br J Vener Dis 59: 311–313

    PubMed  CAS  Google Scholar 

  • Young BJ, Patterson A, Ravenscroft T (1982) A randomised double blind clinical trial of acyclovir ( Zovirax) and adenine arabinoside in herpes simplex corneal ulceration. Br J Ophthalmol 66: 361–363

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Department of Genito-Urinary Medicine, James Pringle House, The Middlesex Hospital, University College and Middlesex School of Medicine, London, W1N 8AA, UK

    Adrian Mindel MB, BCh, MSc, MRCP (Senior Lecturer and Honorary Consultant in Genito-Urinary Medicine)

Authors
  1. Adrian Mindel MB, BCh, MSc, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mindel, A. (1989). Treatment, Prevention and Control. In: Herpes Simplex Virus. The Bloomsbury Series in Clinical Science. Springer, London. https://doi.org/10.1007/978-1-4471-1683-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1683-7_8

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1685-1

  • Online ISBN: 978-1-4471-1683-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation